ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 44 filers reported holding ABEONA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 100 | -50.0% | 0.00% | – |
| Q4 2021 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 200 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 200 | 0.0% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 200 | -0.5% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 201 | +0.5% | 0.00% | – |
| Q4 2017 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2017 | $3,000 | +200.0% | 200 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,359,767 | $3,209,000 | 1.04% |
| DAFNA Capital Management LLC | 181,818 | $429,000 | 0.34% |
| Perceptive Advisors | 1,762,881 | $4,159,000 | 0.29% |
| NEXTHERA CAPITAL LP | 100,000 | $236,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 138,105 | $326,000 | 0.08% |
| Soros Fund Management | 1,462,122 | $3,451,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 270,000 | $637,000 | 0.03% |
| CAMBRIDGE TRUST CO | 65,414 | $154,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 30,000 | $71,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 376,321 | $888,000 | 0.01% |